GE HealthCare Cash Flow Statement
GEHC / Health Care|5 years of annual SEC 10-K data (FY2021-FY2025)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 5 fiscal years. All figures from audited SEC 10-K filings.
GE HealthCare generated $2.0B in operating cash flow and $1.5B in free cash flow in FY2025. Free cash flow margin was 7.3% of revenue.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score 1.14 (distress zone, below 1.8 threshold)
- Strong return on equity: 22.2%
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Net Income | $2.1B | $2.0B | $2.2B | $1.9B | $2.2B |
| Depreciation & Amortization | $287.0M | - | $225.0M | $228.0M | $225.0M |
| Operating Cash Flow | $2.0B | $2.0B | $1.6B | $2.1B | $1.6B |
| Capital Expenditures | $482.0M | $401.0M | $248.0M | $310.0M | $248.0M |
| Free Cash Flow | $1.5B | $1.6B | $1.4B | $1.8B | $1.4B |
| Share Buybacks | $200.0M | $0 | - | - | - |
| Dividends Paid | $64.0M | $55.0M | $0 | $0 | $0 |
| FCF Margin | 7.3% | 7.9% | 7.7% | 9.9% | 7.7% |